AveXis (AVXS) Stock Rating Reaffirmed by BMO Capital Markets

BMO Capital Markets restated their buy rating on shares of AveXis (NASDAQ:AVXS) in a research note published on Thursday morning. They currently have a $150.00 target price on the stock.

A number of other equities research analysts have also issued reports on the stock. Credit Suisse Group began coverage on shares of AveXis in a research note on Wednesday, January 17th. They set an outperform rating and a $134.00 target price for the company. Royal Bank of Canada reissued a hold rating and set a $92.00 target price on shares of AveXis in a research note on Tuesday, January 9th. Zacks Investment Research raised shares of AveXis from a sell rating to a hold rating in a research note on Tuesday, January 9th. Canaccord Genuity set a $110.00 target price on shares of AveXis and gave the company a hold rating in a research note on Friday, January 5th. Finally, Chardan Capital reissued a buy rating and set a $135.00 target price on shares of AveXis in a research note on Friday, January 5th. Three analysts have rated the stock with a sell rating, four have given a hold rating and fourteen have assigned a buy rating to the stock. The stock has an average rating of Buy and a consensus price target of $113.89.

AveXis (AVXS) traded down $1.92 during midday trading on Thursday, reaching $108.25. 777,100 shares of the company’s stock traded hands, compared to its average volume of 788,531. The stock has a market cap of $3,885.52, a PE ratio of -19.40 and a beta of 2.46. AveXis has a 12-month low of $50.56 and a 12-month high of $119.00.

AveXis (NASDAQ:AVXS) last issued its earnings results on Thursday, November 9th. The company reported ($1.52) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.48) by ($0.04). During the same quarter in the prior year, the business earned ($0.87) EPS. research analysts expect that AveXis will post -6.23 earnings per share for the current year.

In other AveXis news, VP Andrew F. Knudten sold 2,000 shares of the business’s stock in a transaction on Monday, December 4th. The shares were sold at an average price of $94.48, for a total transaction of $188,960.00. Following the completion of the transaction, the vice president now owns 7,000 shares of the company’s stock, valued at approximately $661,360. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Brian K. Kaspar sold 15,000 shares of the business’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $101.23, for a total transaction of $1,518,450.00. Following the transaction, the insider now directly owns 1,841,019 shares of the company’s stock, valued at approximately $186,366,353.37. The disclosure for this sale can be found here. In the last ninety days, insiders sold 57,340 shares of company stock valued at $5,851,445. 18.60% of the stock is owned by company insiders.

A number of institutional investors have recently added to or reduced their stakes in the business. Amalgamated Bank lifted its position in AveXis by 19.6% during the 3rd quarter. Amalgamated Bank now owns 3,187 shares of the company’s stock worth $308,000 after acquiring an additional 523 shares during the last quarter. Parametric Portfolio Associates LLC lifted its position in AveXis by 2.9% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 20,943 shares of the company’s stock worth $1,721,000 after acquiring an additional 598 shares during the last quarter. ProShare Advisors LLC lifted its position in AveXis by 6.4% during the 2nd quarter. ProShare Advisors LLC now owns 16,427 shares of the company’s stock worth $1,350,000 after acquiring an additional 985 shares during the last quarter. Strs Ohio acquired a new position in AveXis during the 3rd quarter worth $116,000. Finally, Schwab Charles Investment Management Inc. lifted its position in AveXis by 1.3% during the 4th quarter. Schwab Charles Investment Management Inc. now owns 109,902 shares of the company’s stock worth $12,163,000 after acquiring an additional 1,389 shares during the last quarter. 92.92% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: This piece was posted by BBNS and is the property of of BBNS. If you are accessing this piece on another publication, it was illegally copied and republished in violation of United States & international copyright and trademark law. The legal version of this piece can be accessed at https://baseballnewssource.com/markets/avexis-avxs-stock-rating-reaffirmed-by-bmo-capital-markets/1854234.html.

AveXis Company Profile

AveXis, Inc is a clinical-stage gene therapy company. The Company operates through the developing and commercializing gene therapy treatments for patients suffering from neurological genetic diseases segment. The Company’s product candidate, AVXS-101, is its gene therapy product candidate that is in a Phase I clinical trial for the treatment of spinal muscular atrophy (SMA) Type 1, which is a genetic disorder characterized by motor neuron loss and associated muscle deterioration.

Analyst Recommendations for AveXis (NASDAQ:AVXS)

Receive News & Ratings for AveXis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AveXis and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Cubs Sign Free Agent Yu Darvish
Cubs Sign Free Agent Yu Darvish
Mother of Pittsburgh Pirates Player Elias Diaz Has Been Kidnapped
Mother of Pittsburgh Pirates Player Elias Diaz Has Been Kidnapped


Leave a Reply

 
© 2006-2018 BBNS.